About PPD
PPD is a Healthcare company based in Wilmington (United States) founded in 1985, and was acquired by Thermo Fisher Scientific in April 2021. CRO providing diversified clinical development services. The company has 1,674 employees. PPD has completed 9 acquisitions, including AbCRO, Acurian and Bioduro. Its website ppd.com draws about 227 thousand monthly visits. Its Indian entity Ppd Pharmaceutical Development India Private Limited reported revenue of ₹458 Cr. PPD offers products and services including Clinical Development Services, Laboratory Services, and Functional Service Partnerships. Its focus areas include Biopharma Outsourcing, CRO and Clinical Development. Its competitors include Cambrian BioPharma and DM Clinical; 1 of its 2 listed competitors has raised funding.
Company details
PPD, based in Wilmington, focuses on providing healthcare solutions, biopharma outsourcing, cro, and clinical development. CRO providing diversified clinical development services. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Wilmington, United States
- Employees 1,674
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website ppd.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Thermo Fisher Scientific (Apr 2021)
- Legal Name Ppd Pharmaceutical Development India Private Limited
- Date of Incorporation 10 Feb, 2004
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹458 Cr
FY 2025 · +19% YoY
- Indian entity net profit₹42.97 Cr
FY 2025 · 9% margin
- Indian entity EBITDA₹78.14 Cr
FY 2025 · 17% margin
- Latest Funding Round$126.5M (USD), Grant
Oct 2023
- InvestorsThermo Fisher Scientific
& 2 more
- Employee Count1,674
- Investments & AcquisitionsAbCRO
& 8 more
- Acquired byThermo Fisher Scientific
(Apr 2021)
Associated legal entities of PPD
PPD operates through Ppd Pharmaceutical Development India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ppd Pharmaceutical Development India Private Limited CIN U73100MH2004PTC144454 | Active | 10 Feb 2004 | Mumbai, Maharashtra | ₹458 Cr | 1,674 | 2 | View details |
Products & Services of PPD
PPD offers a comprehensive portfolio of products and services, including Clinical Development Services, Laboratory Services, and Functional Service Partnerships.
Manages phases of clinical trials for drug efficacy
Provides bioanalytical and biomarker testing for trials
Offers specialized project management for biotech needs
Apps and channels of PPD
its YouTube channel PPD has 2.21K subscribers and 30 videos.
Videos from PPD
The most watched videos on PPD's YouTube channel, PPD (2.21K subscribers). Click a video to play it here.
More on PPD.
Funding Insights of PPD
- Total Rounds 6
- Last Round Grant — $126.5M
- First Round $7.07M
(Jul 2005)
- Investors Count 1
All 7 funding rounds of PPD with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $126.5M | Grant | – | – | |
| May 2019 | $900M | Debt – Conventional | – | – | – |
| Dec 2011 | Private Equity Round | – | – | The Carlyle Group | |
| Jan 2011 | Private Equity Round | – | – | ||
| Aug 2009 | $7.07M | Grant | – | – | |
| Jul 2008 | $7.07M | Grant | – | – | |
| Jul 2005 | $7.07M | Grant | – | – |
3 investors in total: 3 institutional.
Investors in PPD
PPD has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Thermo Fisher Scientific, HHS and Hellman & Friedman.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| hf.com | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Electron microscopy services and microanalysis instruments are provided. | 1956 | thermofisher.com | Waltham, United States |
Investor details for PPD
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ppd Pharmaceutical Development India Private Limited (PPD)
Ppd Pharmaceutical Development India Private Limited is the primary company behind PPD. The board of Ppd Pharmaceutical Development India Private Limited currently have 2 directors; the longest-serving is Hemant Shah, appointed in 2020. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Hemant Shah DIN 08834681 | Director | 18 Aug 2020 | 6 yrs 2 mo | Ppd Pharmaceutical Development India Private Limited |
| Rashmi Raja Chitgupi DIN 08914987 | Director | 16 Oct 2020 | 6 yrs | Ppd Pharmaceutical Development India Private Limited |
People of PPD
548 people are tracked at PPD (161 in leadership, 387 in team); the tracked headcount is 1,674.
| Name | Role | Group |
|---|---|---|
Claudia Deveras | Vice President Innovation & Operations Excellence | Leadership |
Grace Geng | Executive Director, China Commercial &alliance Lead | Leadership |
Timothy King | Vice President, Integrated Clinical Solutions, Ppdtranslate | Leadership |
Emily Barbour | Associate Director | Leadership |
Jordanna Devich Assentio | Associate Director Business Development | Leadership |
Seth Morris | Director, Lab Operations | Leadership |
Sayeh Beiglari | Senior Director Business Development | Leadership |
Amy Alexis M. | Associate Director, Regulatory Inspections - Clinical QA | Leadership |
Heidi Young | Senior Director Clinical Operations | Leadership |
Joy Lewis | Director, Peri And Post Approval Reserach Operations | Leadership |
Mary Doyle | Associate Director, CTM | Leadership |
Michael Sharer | Associate Director Lab Informatics | Leadership |
Megan Wiberg | Executive Director, Assay Services And Automation | Leadership |
Bruce Pfannenstiel | Senior Director, Quality Systems Optimization | Leadership |
Patti Rourke | Sr. Director - Global Head Of Clin Ops Resourcing | Leadership |
Meredith Massey | Associate Director, Clinical Management | Leadership |
Paul Grostal | Associate Director, Project Management | Leadership |
Vijay Moolaveesala | Director, Programming | Leadership |
Meghan McMullen | Associate Director, Project Management | Leadership |
Terri Frisbie Myers | Vice President Biotech Operations | Leadership |
528 more people are available in the full profile.
Complete people profiles for PPD
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of PPD
Figures of Ppd Pharmaceutical Development India Private Limited, the primary company behind PPD, for FY 2025. Revenue was ₹458 Cr (+19% year on year). Net profit was ₹42.97 Cr (9% margin). EBITDA was ₹78.14 Cr (17% margin). Revenue has grown at a compounded annual rate of +12% over three years and +21% over five years.
- ₹458 CrRevenue · FY 2025 · +19% YoY
- ₹42.97 CrNet profit · 9% margin
- ₹78.14 CrEBITDA · 17% margin
- ₹3.6 LakhPaid-up capital
- 1,674Employees (provident fund records)
- +12%Revenue CAGR, 3 years
- +21%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ppd Pharmaceutical Development India Private Limited are on its company page.
Detailed financial statements for PPD
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PPD
PPD has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include AbCRO, Acurian and Bioduro.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Evidence-based solutions are provided for biopharmaceutical real-world effectiveness and safety. | evidera.com | Bethesda, United States | 2012 | Sep 2016 | •••• | |
Patient recruitment and retention for clinical trials are managed globally. | synexus.com | Chorley, United Kingdom | 1992 | Jun 2016 | $258M | |
Small molecule drug discovery platform is provided to researchers. | x-chemrx.com | Waltham, United States | 2009 | Sep 2014 | •••• | |
Cinical Trial design | rctlogic.com | Ponte Vedra Beach, United States | 2007 | Sep 2014 | •••• | |
Patient enrollment and retention solutions for clinical trials are offered. | acurian.com | Horsham, United States | 1998 | Aug 2013 | •••• | |
Integrated drug discovery and development services | bioduro.com | San Diego, United States | 2005 | Nov 2009 | $77M | |
Inappropriate content | excel-china.com | Beijing, China | 2009 | Oct 2009 | •••• | |
Novel pharmaceuticals for skin diseases are developed. | magenbiosciences.com | Waltham, United States | 2006 | Apr 2009 | $14.5M | |
Central and Eastern European CRO, acquired by PPD in 2009 and operation | abcro.com | Stamford, United States | 2000 | Feb 2009 | •••• |
Complete acquisition details for PPD
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PPD
14 dated milestones of PPD across 38 years, from founding to its latest funding, stage changes and deals.
- Founded PPD is founded.
- Funding First funding round of $7.1M.
- Acquisition Acquires AbCRO.
- Acquisition Acquires Magen BioSciences.
- Acquisition Acquires Excel China.
- Acquisition Acquires Bioduro.
- Acquisition Acquires Acurian.
- Acquisition Acquires RCT Logic.
- Acquisition Acquires X-Chem.
- Acquisition Acquires Trialmed.
- Acquisition Acquires Evidera.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Thermo Fisher Scientific.
- Funding Latest funding round, Grant, of $126.5M.
Competitors of PPD
PPD has 2 listed competitors in our database, 1 of them funded. They include Cambrian BioPharma and DM Clinical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cambrianbio.com | 2019 | Brooklyn, United States | $211.46M | Medicines and therapies are developed for healthcare applications. | ||
| dmclinicalresearch.com | 2006 | Houston, United States | Conducts Phase I-IV clinical trials connecting patients with physicians for medical research. |
Detailed competitors of PPD
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PPD
The website of PPD (ppd.com) receives about 226.8K visits a month and ranks #271,623 among all websites worldwide, #9,252 in Biotechnology and Pharmaceuticals.
- Monthly visits226.8K
▲ 31% vs previous month
- Unique visitors91.8K
per month
- Global rank#271,623
among all websites
- Category rank#9,252
Health · Biotechnology and Pharmaceuticals
- Bounce rate49%
- Pages per visit1.6
- Average visit31 sec
- DevicesDesktop 22% · Mobile 78%
Websites whose visitors overlap most with PPD. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| covance.com | 100% | 20.2K | #688,229 | View details | |
gonovum.com | gonovum.com | 86% | #1,436,718 | – | |
ppdi.com | ppdi.com | 86% | #404,899 | – | |
| worldwide.com | 82% | 89.1K | #546,596 | View details | |
| signanthealth.com | 80% | 94.5K | #272,978 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for PPD
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as PPD (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ppd
Complete news archive for PPD
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PPD
PPD was founded in 1985 and raised its 1st funding round 20 years after it was founded.
PPD is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
PPD has 1,674 employees.
The primary company behind PPD, Ppd Pharmaceutical Development India Private Limited, reported revenue of ₹458 Cr for FY 2025, up 19% year on year.
PPD, based in Wilmington, focuses on providing healthcare solutions, biopharma outsourcing, cro, and clinical development. CRO providing diversified clinical development services. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
PPD's top competitors include Cambrian BioPharma and DM Clinical.
PPD offers Clinical Development Services, Laboratory Services, and Functional Service Partnerships.
PPD has 3 investors. Key investors include Thermo Fisher Scientific, HHS, and Hellman & Friedman.
PPD operates through Ppd Pharmaceutical Development India Private Limited.
Yes. PPD was acquired by Thermo Fisher Scientific in April 2021.
The legal entities of PPD currently have 2 directors, including Rashmi Raja Chitgupi, Hemant Shah.